REG3A secreted by peritumoral acinar cells enhances pancreatic ductal adenocarcinoma progression via activation of EGFR signaling

Abstract Background Regenerating family member 3A (REG3A) is involved in the development of multiple malignant tumors, including pancreatic ductal adenocarcinoma (PDAC). However, any role of REG3A in PDAC remains controversial due to its unclear tissue localization or direct receptors, and complex d...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaojing Ren, Yunfei Teng, Kunxin Xie, Xiao He, Gang Chen, Kaini Zhang, Qingyi Liao, Jia Zhang, Xiaohang Zhou, Yating Zhu, Wenyu Song, Yuege Lin, Yi Zhang, Zhijian Xu, Noriaki Maeshige, Xiubin Liang, Dongming Su, Peng Sun, Ying Ding
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Cell Communication and Signaling
Subjects:
Online Access:https://doi.org/10.1186/s12964-025-02103-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849715654969524224
author Xiaojing Ren
Yunfei Teng
Kunxin Xie
Xiao He
Gang Chen
Kaini Zhang
Qingyi Liao
Jia Zhang
Xiaohang Zhou
Yating Zhu
Wenyu Song
Yuege Lin
Yi Zhang
Zhijian Xu
Noriaki Maeshige
Xiubin Liang
Dongming Su
Peng Sun
Ying Ding
author_facet Xiaojing Ren
Yunfei Teng
Kunxin Xie
Xiao He
Gang Chen
Kaini Zhang
Qingyi Liao
Jia Zhang
Xiaohang Zhou
Yating Zhu
Wenyu Song
Yuege Lin
Yi Zhang
Zhijian Xu
Noriaki Maeshige
Xiubin Liang
Dongming Su
Peng Sun
Ying Ding
author_sort Xiaojing Ren
collection DOAJ
description Abstract Background Regenerating family member 3A (REG3A) is involved in the development of multiple malignant tumors, including pancreatic ductal adenocarcinoma (PDAC). However, any role of REG3A in PDAC remains controversial due to its unclear tissue localization or direct receptors, and complex downstream signal transductions. Methods Morphological analysis and public multi-omics data retrieval were was utilized to elucidate the tissue localization of REG3A in PDAC. To ascertain the pro-oncogenic role of secreted REG3A, experiments were conducted using in vitro PDAC cell lines and in vivo tumor formation assays in nude mice. A battery of investigative techniques, including RNA sequencing, phospho-kinase arrays, western blot analyses, in silico docking simulations, gene truncation strategies, and co-immunoprecipitation, were employed to delve into the downstream signaling transduction pathways induced by REG3A. Results In this study, we confirmed an association between increased serum levels of REG3A and poor prognosis in patients with PDAC. Morphological staining and bioinformatic analysis showed that REG3A was mainly expressed in peritumoral acinar cells that were spatially close to tumor region, while it was almost negative in PDAC tumor cells. Peritumoral REG3A expression levels, but not tumoral REG3A, were highly correlated with PDAC progression. Further in vitro experiments including RNA sequencing and molecular biological assays revealed that secreted REG3A could directly bind to the epidermal growth factor receptor (EGFR), an important pro-oncogene involved in cellular proliferation, and subsequently activate the downstream mitogen-activated protein kinase (MAPK) signals to promote PDAC tumor cell growth. Conclusion Taken together, our data indicated that increased expression of REG3A in peritumoral acinar cells acts as a specific event to indicate PDAC progression, and verified EGFR as a possible target of REG3A, providing mechanistic insights into the role of REG3A, the diagnostic method and therapeutic strategy of PDAC.
format Article
id doaj-art-81a1084ca6374d7a9be04ddcb03eb949
institution DOAJ
issn 1478-811X
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series Cell Communication and Signaling
spelling doaj-art-81a1084ca6374d7a9be04ddcb03eb9492025-08-20T03:13:15ZengBMCCell Communication and Signaling1478-811X2025-02-0123111910.1186/s12964-025-02103-4REG3A secreted by peritumoral acinar cells enhances pancreatic ductal adenocarcinoma progression via activation of EGFR signalingXiaojing Ren0Yunfei Teng1Kunxin Xie2Xiao He3Gang Chen4Kaini Zhang5Qingyi Liao6Jia Zhang7Xiaohang Zhou8Yating Zhu9Wenyu Song10Yuege Lin11Yi Zhang12Zhijian Xu13Noriaki Maeshige14Xiubin Liang15Dongming Su16Peng Sun17Ying Ding18Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi HospitalDepartment of Pathology, Nanjing Medical UniversityKey Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical UniversityDepartment of Pathology, Nanjing Medical UniversityDepartment of Pathology, Nanjing Medical UniversityDepartment of Pathophysiology, Nanjing Medical UniversityState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesKey Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical UniversityKey Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical UniversityKey Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical UniversityKey Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical UniversityDepartment of Pathology, Nanjing Medical UniversityDepartment of Pathology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer HospitalState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesDepartment of Rehabilitation Science, Kobe University Graduate School of Health SciencesDepartment of Pathophysiology, Nanjing Medical UniversityDepartment of Pathology, Nanjing Medical UniversityKey Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical UniversityDepartment of Pathology, the First Affiliated Hospital of Nanjing Medical UniversityAbstract Background Regenerating family member 3A (REG3A) is involved in the development of multiple malignant tumors, including pancreatic ductal adenocarcinoma (PDAC). However, any role of REG3A in PDAC remains controversial due to its unclear tissue localization or direct receptors, and complex downstream signal transductions. Methods Morphological analysis and public multi-omics data retrieval were was utilized to elucidate the tissue localization of REG3A in PDAC. To ascertain the pro-oncogenic role of secreted REG3A, experiments were conducted using in vitro PDAC cell lines and in vivo tumor formation assays in nude mice. A battery of investigative techniques, including RNA sequencing, phospho-kinase arrays, western blot analyses, in silico docking simulations, gene truncation strategies, and co-immunoprecipitation, were employed to delve into the downstream signaling transduction pathways induced by REG3A. Results In this study, we confirmed an association between increased serum levels of REG3A and poor prognosis in patients with PDAC. Morphological staining and bioinformatic analysis showed that REG3A was mainly expressed in peritumoral acinar cells that were spatially close to tumor region, while it was almost negative in PDAC tumor cells. Peritumoral REG3A expression levels, but not tumoral REG3A, were highly correlated with PDAC progression. Further in vitro experiments including RNA sequencing and molecular biological assays revealed that secreted REG3A could directly bind to the epidermal growth factor receptor (EGFR), an important pro-oncogene involved in cellular proliferation, and subsequently activate the downstream mitogen-activated protein kinase (MAPK) signals to promote PDAC tumor cell growth. Conclusion Taken together, our data indicated that increased expression of REG3A in peritumoral acinar cells acts as a specific event to indicate PDAC progression, and verified EGFR as a possible target of REG3A, providing mechanistic insights into the role of REG3A, the diagnostic method and therapeutic strategy of PDAC.https://doi.org/10.1186/s12964-025-02103-4REG3APancreatic ductal adenocarcinomaPeritumoral acinar cellEpidermal growth factor receptor (EGFR)Paracrine
spellingShingle Xiaojing Ren
Yunfei Teng
Kunxin Xie
Xiao He
Gang Chen
Kaini Zhang
Qingyi Liao
Jia Zhang
Xiaohang Zhou
Yating Zhu
Wenyu Song
Yuege Lin
Yi Zhang
Zhijian Xu
Noriaki Maeshige
Xiubin Liang
Dongming Su
Peng Sun
Ying Ding
REG3A secreted by peritumoral acinar cells enhances pancreatic ductal adenocarcinoma progression via activation of EGFR signaling
Cell Communication and Signaling
REG3A
Pancreatic ductal adenocarcinoma
Peritumoral acinar cell
Epidermal growth factor receptor (EGFR)
Paracrine
title REG3A secreted by peritumoral acinar cells enhances pancreatic ductal adenocarcinoma progression via activation of EGFR signaling
title_full REG3A secreted by peritumoral acinar cells enhances pancreatic ductal adenocarcinoma progression via activation of EGFR signaling
title_fullStr REG3A secreted by peritumoral acinar cells enhances pancreatic ductal adenocarcinoma progression via activation of EGFR signaling
title_full_unstemmed REG3A secreted by peritumoral acinar cells enhances pancreatic ductal adenocarcinoma progression via activation of EGFR signaling
title_short REG3A secreted by peritumoral acinar cells enhances pancreatic ductal adenocarcinoma progression via activation of EGFR signaling
title_sort reg3a secreted by peritumoral acinar cells enhances pancreatic ductal adenocarcinoma progression via activation of egfr signaling
topic REG3A
Pancreatic ductal adenocarcinoma
Peritumoral acinar cell
Epidermal growth factor receptor (EGFR)
Paracrine
url https://doi.org/10.1186/s12964-025-02103-4
work_keys_str_mv AT xiaojingren reg3asecretedbyperitumoralacinarcellsenhancespancreaticductaladenocarcinomaprogressionviaactivationofegfrsignaling
AT yunfeiteng reg3asecretedbyperitumoralacinarcellsenhancespancreaticductaladenocarcinomaprogressionviaactivationofegfrsignaling
AT kunxinxie reg3asecretedbyperitumoralacinarcellsenhancespancreaticductaladenocarcinomaprogressionviaactivationofegfrsignaling
AT xiaohe reg3asecretedbyperitumoralacinarcellsenhancespancreaticductaladenocarcinomaprogressionviaactivationofegfrsignaling
AT gangchen reg3asecretedbyperitumoralacinarcellsenhancespancreaticductaladenocarcinomaprogressionviaactivationofegfrsignaling
AT kainizhang reg3asecretedbyperitumoralacinarcellsenhancespancreaticductaladenocarcinomaprogressionviaactivationofegfrsignaling
AT qingyiliao reg3asecretedbyperitumoralacinarcellsenhancespancreaticductaladenocarcinomaprogressionviaactivationofegfrsignaling
AT jiazhang reg3asecretedbyperitumoralacinarcellsenhancespancreaticductaladenocarcinomaprogressionviaactivationofegfrsignaling
AT xiaohangzhou reg3asecretedbyperitumoralacinarcellsenhancespancreaticductaladenocarcinomaprogressionviaactivationofegfrsignaling
AT yatingzhu reg3asecretedbyperitumoralacinarcellsenhancespancreaticductaladenocarcinomaprogressionviaactivationofegfrsignaling
AT wenyusong reg3asecretedbyperitumoralacinarcellsenhancespancreaticductaladenocarcinomaprogressionviaactivationofegfrsignaling
AT yuegelin reg3asecretedbyperitumoralacinarcellsenhancespancreaticductaladenocarcinomaprogressionviaactivationofegfrsignaling
AT yizhang reg3asecretedbyperitumoralacinarcellsenhancespancreaticductaladenocarcinomaprogressionviaactivationofegfrsignaling
AT zhijianxu reg3asecretedbyperitumoralacinarcellsenhancespancreaticductaladenocarcinomaprogressionviaactivationofegfrsignaling
AT noriakimaeshige reg3asecretedbyperitumoralacinarcellsenhancespancreaticductaladenocarcinomaprogressionviaactivationofegfrsignaling
AT xiubinliang reg3asecretedbyperitumoralacinarcellsenhancespancreaticductaladenocarcinomaprogressionviaactivationofegfrsignaling
AT dongmingsu reg3asecretedbyperitumoralacinarcellsenhancespancreaticductaladenocarcinomaprogressionviaactivationofegfrsignaling
AT pengsun reg3asecretedbyperitumoralacinarcellsenhancespancreaticductaladenocarcinomaprogressionviaactivationofegfrsignaling
AT yingding reg3asecretedbyperitumoralacinarcellsenhancespancreaticductaladenocarcinomaprogressionviaactivationofegfrsignaling